IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 13654 
Small font sizeDefault font sizeIncrease font size
Navigate Here
  »   My Preferences 
  »   Manuscript submission


This article has been cited by
1Assessment of adverse events related to anti-influenza neuraminidase inhibitors using the FDA adverse event reporting system and online patient reviews
Nayoung Han,Jung Mi Oh,In-Wha Kim
Scientific Reports.2020;10(1)
2Antiviral Treatments for Influenza
Emanuele Palomba,Valeria Castelli,Giulia Renisi,Alessandra Bandera,Andrea Lombardi,Andrea Gori
Seminars in Respiratory and Critical Care Medicine.2021;42(06)859
3Antiviral Treatments for Influenza
Maria Sole Vallecoccia,Orla Anne Murphy,Alejandro H. Rodriguez,Ignacio Martin-Loeches
Seminars in Respiratory and Critical Care Medicine.2022;42(06)350
4Exploring the chemical space of influenza neuraminidase inhibitors
Nuttapat Anuwongcharoen,Watshara Shoombuatong,Tanawut Tantimongcolwat,Virapong Prachayasittikul,Chanin Nantasenamat
5Opportunities for the development of novel therapies based on host-microbial interactions
Patrícia Campi Santos,Mauro Martins Teixeira,Danielle G. Souza
Pharmacological Research.2016;112(06)68
6Discovery of novel potent drugs for influenza by inhibiting the vital function of neuraminidase via fragment-based drug design (FBDD) and molecular dynamics simulation strategies
Lotfi Bourougaa,Mebarka Ouassaf,Amneh Shtaiwi
Journal of Biomolecular Structure and Dynamics.2023;112(06)1
7Safety and effectiveness of neuraminidase inhibitors in situations of pandemic and/or novel/variant influenza: a systematic review of the literature, 2009–15
C. Boikos,C. Caya,M. K. Doll,H. Kraicer-Melamed,M. Dolph,G. Delisle,N. Winters,G. Gore,C. Quach
Journal of Antimicrobial Chemotherapy.2017;72(6)1556
8Oseltamivir and baloxavir: Dual treatment for rapidly developing ARDS on a patient with renal disease
Pool Tobar Vega,Elena Caldeira,Hasan Abad,Peguy Saad,Erik Lachance
Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer | Privacy Notice
Online since 20th July '04
Published by Wolters Kluwer - Medknow